Literature DB >> 16367896

Aspirin resistance in secondary stroke prevention.

J Berrouschot1, B Schwetlick, G von Twickel, C Fischer, H Uhlemann, T Siegemund, A Siegemund, A Roessler.   

Abstract

BACKGROUND: We investigated the platelet function in stroke patients treated with aspirin [acetylsalicylic acid (ASA)] for secondary stroke prevention during a follow-up period of 1 year.
METHODS: In this prospective study 291 patients with first initiated aspirin therapy (300 mg/day) for secondary stroke prevention were included. Platelet aggregation measurements were performed 24 h, 3, 6, and 12 months after starting medication.
RESULTS: Twenty-one of 291 patients (7.2%) were identified as primary ASA-non-responders (initial insufficient platelet inhibition) and 4.1% as secondary ASA-non-responders (insufficient platelet inhibition during follow-up). There were no significant differences between ASA-responders and ASA-non-responders concerning age, gender, risk factors, and stroke characteristics.
CONCLUSION: Aspirin resistance in stroke patients is not uncommon. The clinical usefulness of routine platelet function tests needs to be proved by further trials.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16367896     DOI: 10.1111/j.1600-0404.2005.00419.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  10 in total

1.  Measurement of platelet reactivity of patients with cardiovascular disease on-treatment with acetyl salicylic acid: a prospective study.

Authors:  Abdalla Awidi; Akram Saleh; Manar Dweik; Baraah Kailani; Mohammed Abu-Fara; Rinad Nabulsi; Abdulbari Bener
Journal:  Heart Vessels       Date:  2010-12-23       Impact factor: 2.037

2.  Aspirin resistance: Fact or fiction? A point of view.

Authors:  Jawahar L Mehta; Bhavna Mohandas
Journal:  World J Cardiol       Date:  2010-09-26

3.  Aspirin resistance in patients with acute ischemic stroke.

Authors:  Serkan Ozben; Beste Ozben; Azra Meryem Tanrikulu; Feriha Ozer; Tomris Ozben
Journal:  J Neurol       Date:  2011-04-21       Impact factor: 4.849

Review 4.  Antiplatelet resistance in stroke.

Authors:  Mehmet Akif Topçuoglu; Ethem Murat Arsava; Hakan Ay
Journal:  Expert Rev Neurother       Date:  2011-02       Impact factor: 4.618

5.  The evaluation method for antiplatelet effect of acetylsalicylic acid.

Authors:  Haruko Yokoyama; Takashi Mastumura; Shinji Soeda; Yuji Suzuki; Masayuki Watanabe; Emiko Kashiwakura; Takayuki Saso; Noriyuki Ikeda; Kentaro Tokuoka; Yasuhisa Kitagawa; Yasuhiko Yamada
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2013-12-22       Impact factor: 2.441

6.  Aspirin resistance in hypertensive patients.

Authors:  Beste Ozben; Azra M Tanrikulu; Tomris Ozben; Oguz Caymaz
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-09       Impact factor: 3.738

7.  Resistance to acetylsalicylic acid in patients with type 2 diabetes mellitus is associated with lipid disorders and history of current smoking.

Authors:  B Łabuz-Roszak; K Pierzchała; K Tyrpień
Journal:  J Endocrinol Invest       Date:  2014-01-09       Impact factor: 4.256

8.  Searching for factors associated with resistance to acetylsalicylic acid used for secondary prevention of stroke.

Authors:  Beata Łabuz-Roszak; Krystyna Pierzchała; Ewa Niewiadomska; Michał Skrzypek; Agnieszka Machowska-Majchrzak
Journal:  Arch Med Sci       Date:  2015-03-14       Impact factor: 3.318

9.  Frequency of Aspirin Resistance in Ischemic Stroke Patients and Healthy Controls from Colombia.

Authors:  Alejandro Roman-Gonzalez; Carlos Andrés Naranjo; Walter D Cardona-Maya; Dionis Vallejo; Francisco Garcia; Cesar Franco; Leonor Alvarez; Luis Ignacio Tobón; Marta Ibeth López; Carolina Rua; Gabriel Bedoya; Ángela Cadavid; José Domingo Torres
Journal:  Stroke Res Treat       Date:  2021-05-21

10.  Biochemical aspirin resistance is associated with increased stroke severity and infarct volumes in ischemic stroke patients.

Authors:  Xuan Cheng; Nan-Chang Xie; Hong-Liang Xu; Chen Chen; Ya-Jun Lian
Journal:  Oncotarget       Date:  2017-08-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.